Medical devices banane wali company Sahajanand Medical Technologies apna IPO **15 October 2026** ko la rahi hai. Yaad rahe, ye poora **100% Offer for Sale (OFS)** hai, matlab company ko koi naya fund nahi milega.
IPO ki basic details
Mumbai ki company Sahajanand Medical Technologies apna pehla IPO lekar aa rahi hai. Subscription 15 October 2026 se shuru hoga aur 19 October 2026 tak chalega. Sabse zaroori baat ye hai ki ye IPO 100% Offer for Sale (OFS) hai. Iska matlab saaf hai—company mein koi naya paisa nahi aa raha, purane investors apna hissa bech kar nikal rahe hain.
Business aur Financials
Company cardiovascular medical devices jaise ki coronary stents aur TAVI systems banati hai. FY26 mein company ka total income ₹1,218.73 Crore raha aur Profit after tax ₹69.08 Crore raha. Company ki revenue growth toh dikh rahi hai, lekin purane record mein losses bhi rahe hain aur profit margin kaafi patle (thin) hain.
Investor ke liye Risks
IPO mein paisa lagane se pehle ye points zaroor check karein:
- Product Concentration: Inki bahut zyada kamayi sirf ek product 'Supraflex Cruz' stent par depend karti hai. Agar is product ka market pressure mein aaya, toh company ke results par seedha asar padega.
- Legal Pange: Promoters par kuch pending criminal aur tax-related cases hain, jo management ke focus aur future mein uncertainty badha sakte hain.
- No Growth Capital: Kyunki ye OFS hai, toh IPO se aane wala paisa company ke expansion ya debt kam karne mein kaam nahi aayega.
Medical device sector kaafi competitive hai. Company apni market share kaise bachati hai aur profitability ko kaise maintain karti hai, ye dekhna hoga. Allotment aur listing BSE aur NSE par 23 October 2026 ke aas-paas hone ki umeed hai.